Results 201 to 210 of about 34,802 (246)

Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol. [PDF]

Front Neurol
Chen Y, Shen P, Zhou G, Xu W, Wan Y, Wang C.   +5 more
europepmc   +1 more source

Association of steroid regimens and withdrawal with relapse risk in myasthenia gravis: a real-world cohort study. [PDF]

Front Neurol
Huang Y, Tan Y, Yan J, Guan Y.
europepmc   +1 more source

Absolute Receptor Occupancy, Not Rate of Decline, Predicts Relapse. [PDF]

Schizophr Bull
McCutcheon RA, Pillinger T, Rubio JM, Taylor D, Jauhar S.   +4 more
europepmc   +1 more source

Patient- and Clinician-Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non-Cancer Pain: A Systematic Review. [PDF]

Clin Pharmacol Ther
Marcelo AC, Hilmer SN, Hunter DJ, Mathieson S, Mohamed R, Li L, Fung N, Yue A, Ferreira ML.   +8 more
europepmc   +1 more source

Pharmacist-Led Taper with Brief Mindfulness-Informed Cognitive Behavioral Therapy for Benzodiazepine Deprescribing in Older Adults: A Pilot Trial. [PDF]

J Gen Intern Med
Anderson TS, Kraemer KM, McCann ML, Wang BX, Lindenberg JH, Yeh GY.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

P123 Biologic dose tapering: a patient perspective

Rheumatology, 2023
Abstract Background/Aims Biological therapies target specific pathways within the inflammatory process involved in the pathogenesis of rheumatoid arthritis. They are costly and can be associated with side-effect burden for patients.
Rayan Rahman, Celia Beynon
openaire   +1 more source

Gradual Dose Taper Following Chronic Buprenorphine

The American Journal on Addictions, 2001
This paper describes the time course of withdrawal and relapse in opioid‐dependent volunteers (n = 8) who completed a gradual outpatient buprenorphine dose taper (28 days). Compliance with treatment was very high, as evidenced by clinic attendance (96–100%).
A B, Becker, E C, Strain, G E, Bigelow, M L, Stitzer, R E, Johnson   +4 more
openaire   +2 more sources

Diazepam tapering in detoxification for high-dose benzodiazepine abuse

Clinical Pharmacology and Therapeutics, 1984
The clinical characteristics and management of patients who abuse high doses of benzodiazepines are not well described. In a prospective open study, 23 subjects who abused high doses of benzodiazepines were admitted for detoxification. Urine or blood test results confirmed benzodiazepine use in all but one subject and multiple drug use in eight (35 ...
M, Harrison, U, Busto, C A, Naranjo, H L, Kaplan, E M, Sellers   +4 more
openaire   +2 more sources

Methadone at tapered doses for the management of opioid withdrawal

2003
Despite widespread use in many countries of tapered methadone for detoxification from opiate dependence, the evidence of efficacy to prevent relapse and promote lifestyle change has not been systematically evaluated.To determine whether tapered methadone is effective to manage opioids withdrawal.We searched: the Cochrane Controlled Trials Register ...
L, Amato, M, Davoli, M, Ferri, R, Ali
openaire   +6 more sources